Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Fibrinogen concentrate for acquired hypofibrinogenaemic states.

Weinkove R, Rangarajan S.

Transfus Med. 2008 Jun;18(3):151-7. doi: 10.1111/j.1365-3148.2008.00854.x.

PMID:
18598277
2.

Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations.

Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sørensen B.

Br J Anaesth. 2008 Dec;101(6):769-73. doi: 10.1093/bja/aen270. Epub 2008 Sep 25.

PMID:
18818192
3.

Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding.

Danés AF, Cuenca LG, Bueno SR, Mendarte Barrenechea L, Ronsano JB.

Vox Sang. 2008 Apr;94(3):221-6. doi: 10.1111/j.1423-0410.2007.01024.x. Epub 2008 Jan 2.

PMID:
18179679
4.

Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register.

Weiss G, Lison S, Glaser M, Herberger S, Johanning K, Strasser T, Huber T, Spannagl M, Heindl B.

Blood Coagul Fibrinolysis. 2011 Dec;22(8):727-34. doi: 10.1097/MBC.0b013e32834cb343.

PMID:
22024795
5.

Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia.

Theodoulou A, Berryman J, Nathwani A, Scully M.

Transfus Apher Sci. 2012 Apr;46(2):159-62. doi: 10.1016/j.transci.2011.11.005. Epub 2012 Jan 9.

PMID:
22227402
6.

Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiency.

Peyvandi F.

Thromb Res. 2009 Dec;124 Suppl 2:S9-11. doi: 10.1016/S0049-3848(09)70158-6.

PMID:
20109654
7.

A critical evaluation of cryoprecipitate for replacement of fibrinogen.

Sørensen B, Bevan D.

Br J Haematol. 2010 Jun;149(6):834-43. doi: 10.1111/j.1365-2141.2010.08208.x. Epub 2010 Apr 29.

PMID:
20456356
8.

Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency.

Kreuz W, Meili E, Peter-Salonen K, Haertel S, Devay J, Krzensk U, Egbring R.

Transfus Apher Sci. 2005 Jun;32(3):247-53.

PMID:
15919240
9.

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage.

Bell SF, Rayment R, Collins PW, Collis RE.

Int J Obstet Anesth. 2010 Apr;19(2):218-23. doi: 10.1016/j.ijoa.2009.08.004. Epub 2010 Mar 2.

PMID:
20194010
10.

The efficacy and safety of cryoprecipitate in the treatment of acquired hypofibrinogenaemia.

Idris SF, Hadjinicolaou AV, Sweeney M, Winthrop C, Balendran G, Besser M.

Br J Haematol. 2014 Aug;166(3):458-61. doi: 10.1111/bjh.12864. Epub 2014 Apr 12. No abstract available.

PMID:
24725203
11.

Pharmacokinetics and safety of fibrinogen concentrate.

Manco-Johnson MJ, Dimichele D, Castaman G, Fremann S, Knaub S, Kalina U, Peyvandi F, Piseddu G, Mannucci P; FIBRINOGEN CONCENTRATE STUDY GROUP.

J Thromb Haemost. 2009 Dec;7(12):2064-9. doi: 10.1111/j.1538-7836.2009.03633.x. Epub 2009 Oct 5.

12.

National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia.

Gollop ND, Chilcott J, Benton A, Rayment R, Jones J, Collins PW.

Transfus Med. 2012 Oct;22(5):350-5. doi: 10.1111/j.1365-3148.2012.01168.x. Epub 2012 Jun 14.

PMID:
22697297
13.

Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P).

Dickneite G, Pragst I, Joch C, Bergman GE.

Blood Coagul Fibrinolysis. 2009 Oct;20(7):535-40. doi: 10.1097/MBC.0b013e32832da1c5. Review.

PMID:
19710609
14.

Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery.

Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A, Pichlmaier M.

J Thorac Cardiovasc Surg. 2009 Sep;138(3):694-702. doi: 10.1016/j.jtcvs.2008.11.065. Epub 2009 May 17.

15.

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study.

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O' Riordan JM, Byrne BM.

Transfus Med. 2012 Oct;22(5):344-9. doi: 10.1111/j.1365-3148.2012.01178.x.

PMID:
22994449
16.

Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.

Solomon C, Pichlmaier U, Schoechl H, Hagl C, Raymondos K, Scheinichen D, Koppert W, Rahe-Meyer N.

Br J Anaesth. 2010 May;104(5):555-62. doi: 10.1093/bja/aeq058. Epub 2010 Mar 26.

17.

Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study.

Rahe-Meyer N, Pichlmaier M, Haverich A, Solomon C, Winterhalter M, Piepenbrock S, Tanaka KA.

Br J Anaesth. 2009 Jun;102(6):785-92. doi: 10.1093/bja/aep089. Epub 2009 May 2.

18.

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial.

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

J Thorac Cardiovasc Surg. 2014 Oct;148(4):1647-55. doi: 10.1016/j.jtcvs.2014.04.029. Epub 2014 Apr 18.

PMID:
24951020
19.

Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.

Levi M, Toh CH, Thachil J, Watson HG.

Br J Haematol. 2009 Apr;145(1):24-33. doi: 10.1111/j.1365-2141.2009.07600.x. Epub 2009 Feb 12.

PMID:
19222477
20.

Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate.

Elliott BM, Aledort LM.

Expert Rev Hematol. 2013 Jun;6(3):277-86. doi: 10.1586/ehm.13.22. Review.

PMID:
23782082

Supplemental Content

Support Center